2023 Publications

Here is a complete list of Lab publications on PubMed

Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Mueller S, Fangusaro J, Thomas AO, Jacques TS, Bandopadhayay P, de Blank P, Packer RJ, Fouladi M, van Meetern AS, Jones DT, Perry A, Nakano Y, Hargrave D, Riedl D, Robinson NJ, Partanen M, Fisher MJ, Witt O. Neuro Oncol. 2023 Dec 26: noad227. dpi:10.1093/neuonc/noad227. Online ahead of print.

A road map for the treatment of pediatric diffuse midline glioma
Koschmann C, Al-Holou WN, Alonso MM, Anastas J, Bandopadhayay P, Barron T, Becher O, Cartaxo R, Castro MG, Chung C, Clausen M, Dang D, Doherty R, Duchatel R, Dun M, Filbin M, Franson A, Galban S, Moure MG, Garton H, Gowda P, Marques JG, Hawkins C, Heath A, Hulleman E, Ji S, Jones C, Kilburn L, Kline C, Koldobskiy MA, Lim D, Lowenstein PD, Lu QR, Lum J, Mack S, Magge S, Marini B, Martin D, Marupudi N, Messinger D, Mody R, Morgan M, Mota M, Muraszko K, Mueller S, Natarajan SK, Nazarian J, Niculcea M, Nuechterlein N, Okado H, Opipari V, Pai MP, Pal S, Peterson E, Phoenix T, Prensner JR, Pun M, Raju GP, Reitman ZJ, REsnick A, Rogawski D, Saratsis A, Sbergio SG, Souweidane M, Stafford JM, Tzaridis T, Venkataraman S, Vittorio O, Wadden J, Wahl D, Wechsler-Reya RJ, Yadav VN, Zhang X, Zhang Q, Venneti S. Cancer Cell. 2023 Nov 20: S1535-6108(23)00393-8. doi:10.1016/j.ccell.2023.11.002. Online ahead of print.

Pediatric low-grade glioma: State-of-the-art and ongoing challenges
Fangusaro J, Jones DT, Packer RJ, Gutmann DH, Milde T, Witt O, Mueller S, Fisher MJ, Hansford JR, Tabori U, Hargrave D, Bandopadhayay P. Neuro Oncol. 2023 Nov 7; noad195. doi:10.1093/neuonc/noad195. Online ahead of print.

Indoximod-based chemo-immunotherapy for pediatric brain tumors: a first-in-children phase 1 trial
Johnson TS, MacDonald TJ, Pacholczyk, Aguilera D, Al-Basheer A, Bajaj M, Bandopadhayay P, Berrong Z, Bouffet E, Castellino RC, Dorris K, Eaton BR, Esiashvili N, Fangusaro JR, Foreman N, Fridlyand D, Giller C, Heger IM, Huang C, Kadom N, Kennedy EP, Manoharan N, Martin W, McDonough C, Parker RS, Ramaswamy V, Ring E, Rojiani A, Sadek RF, Satpathy S, Schniederjan M, Smith A, Smith C, Thomas BE, Vaizer R, Yeo KK, Bhasin MJ, Munn DH. Neuro Oncol. 2023 Sep 16; noad176. doi:10.1093/neuonc/noad174. Online ahead of print.

The ‘LOGGIC’ of RNA-sequencing in enhancing diagnoses of pediatric low-grade gliomas
Apfelbaum A & Bandopadhayay P. Neuro Oncol. 2023 Aug 2; noad142. doi:10.1093/neuonc/noad142. Online ahead of print.

A pilot study omitting radiation in the treatment of children with newly diagnosed WNT-activated medulloblastoma.
Cohen K, Munjapara V, Aguilera D, Castellino RC, Stapleton SL, Landi D, Ashley DM, Rodriguez FJ, Hawkins C, Yang E, London W, Chi S, Bandopadhayay P. Clin Cancer Res. 2023 July 27, CCR-23–348. doi:10.1158/1078. CCR-23-0348. Online ahead of print.

Genome-wide pooled CRISPR screening in neurospheres.
Abid T*, Goodale AB*, Kalani Z, Wyatt M, Gonzalez EM, Zhou KN, Qian K, Novikov D, Condurat AL, Bandopadhayay P#, Piccioni F#, Persky NS# & Root DE#. Nat Protocols. 2023 June 7. doi:10.1038/s41596-023-00835-6. Online ahead of print.

Accurate diagnosis of pediatric brain cancers.
Bandopadhayay P & Mardis E. Nat Medicine. 2023 Mar 17. doi:10.1038/s41591-023-02254-2. Online ahead of print.

Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment.
Tsai J, Choi JJ, Quaalam H, Murillo EA, Yeo KK, Vogelzang J, Sousa C, Woods JK, Ligon KL, Warfield SK, Bandopadhayay P, Cooney T. Neurooncol Advances. 2022 Dec 18;5(1):vdac182. doi:10.1093/noajnl/vdac182. Ecollection 2023 Jan-Dec.  

ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma. 
Blandin AF,  Giglio R, Graham MS, Garcia G, Malinowski S, Woods JK, Ramkissoon S, Ramkissoon L, Dubois F, Schoolcraft K, Tsai J, Wang D, Jones R, ,Vogelzang J, Pelton K, Becker S, Watkinson F, Sinai C, Cohen EF, Booker MA, Tolstorukov MY, Haemels V, Goumnerova L, Wright K, Kieran M, Fehnel K, Reardon D, Tauziede-Espariat A, Lulla R, Carcamo B, Chaleff S, Charest A, De Smet F, Ligon AH, Dubuc A, Pages M, Varlet P, Wen PY, Alexander BM, Chi S, Alexandrescu S, Kittler R, Bachoo R, Bandopadhayay P#, Beroukhim R#, Ligon KL#. Clin Cancer Research. 2023 Feb 13; CCR-21-3521. doi:10.1158/1078-0432. CCR-21-3521.  

Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era.
Manoharan N, Liu KX, Mueller, S, Haas-Kogan D, Bandopadhayay P.  Neoplasia. 2023 Feb; 36:100857. doi:10.1016/j. neo.2022.100857. Epub 2022 Dec 24.

K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midbrain gliomas
Jessa S, Mohammadnia A, Harutyunyan AS, Hulswit M, Varadharajan S, Lakkis H, Kabir N, Bashardanesh Z, Hebert S, Faury D, Vladoiu MC, Worme S, Coutelier M, Krug B, Andrade AF, Pathania M, Bajic A, Weil AG, Ellezam B, Atkinson J, Dudley RWR, Farmer JP, Perreault S, Garcia BA, Larouche V, Blanchette M, Garzia L, Bhaduri A, Ligon KL, Bandopadhayay P, Taylor MD, Mack SC, Jabado N, Kleinman CL.   Nat Genetics. 2022 Dec; 54(12); 1865-1880 doi:10.1038/s41588-022-01205-w. Epub 2022 Dec 5.

Comments are closed